Pharmacologic management of neuropathic pain: Evidence-based recommendations

Pain

Volumn 132, Issue 3, 2007, Pages 237-251

  Dworkin, Robert H ^a   O'Connor, Alec B ^a   Backonja, Miroslav ^b   Farrar, John T ^c   Finnerup, Nanna B ^d   Jensen, Troels S ^d   Kalso, Eija A ^e   Loeser, John D ^f   Miaskowski, Christine ^g   Nurmikko, Turo J ^h   Portenoy, Russell K ⁱ   Rice, Andrew S C ^j   Stacey, Brett R ^k   Treede, Rolf Detlef ^l   Turk, Dennis C ^f   Wallace, Mark S ^m  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ BETH ISRAEL MEDICAL CENTER   (United States)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l JOHANNES GUTENBERG UNIVERSITY   (Germany)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Evidence based recommendations; Neuropathic pain; Pharmacologic management; Randomized clinical trials

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; DESIPRAMINE; DULOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MEXILETINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OXCARBAZEPINE; OXYCODONE; PAROXETINE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ANALGESIA; BLURRED VISION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DIZZINESS; DROWSINESS; DRUG BINDING; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LOW DRUG DOSE; META ANALYSIS; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SINUS TACHYCARDIA; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

ANIMALS; EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HUMANS; NEURALGIA; PAIN;

EID: 35748943212     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2007.08.033     Document Type: Review

References (135)

1. Adams E.H., Breiner S., Cicero T.J., Geller A., Inciardi J.A., Schnoll S.H., et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 31 (2006) 465-476
2. Angst M.S., and Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104 (2006) 570-587
3. Attal N., Cruccu G., Haanpää M., Hansson P., Jensen T.S., Nurmikko T., et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
4. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 280 (1998) 1831-1836
5. Backonja M., and Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 25 (2003) 81-104
6. Ballantyne J.C., and LaForge K.S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129 (2007) 235-255
7. Bennett G.J. Neuropathic pain: an overview. In: Borsook D. (Ed). Molecular neurobiology of pain (1997), IASP Press, Seattle, WA 109-113
8. Beydoun A., Shaibani A., Hopwood M., and Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 113 (2006) 395-404
9. Bond M., Breivik H., Jensen T.S., Scholten W., Soyannwo O., and Treede R.D. Pain associated with neurological disorders. In: Aarli J.A., Dua T., Janca A., and Muscetta A. (Eds). Neurological disorders: public health challenges (2006), World Health Organization Press, Geneva 127-139
10. Bone M., Critchley P., and Buggy D.J. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med 27 (2002) 481-486
11. Boureau F., Legallicier P., and Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 104 (2003) 323-331
12. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 3 (1999) 335-342
13. In: Campbell J.N., Basbaum A.I., Dray A., Dubner R., Dworkin R.H., and Sang C.N. (Eds). Emerging strategies for the treatment of neuropathic pain (2006), IASP Press, Seattle
14. Caraceni A., Zecca E., Bonezzi C., Arcuri E., Tur R.Y., Maltoni M., et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group. J Clin Oncol 22 (2004) 2909-2917
15. Cardenas D.D., Warms C.A., Turner J.A., Marshall H., Brooke M.M., and Loeser J.D. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 96 (2002) 365-373
16. Chang G., Chen L., and Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 91 (2007) 199-211
17. Chu L.F., Clark D.J., and Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7 (2006) 43-48
18. Cicero T.J., Inciardi J.A., Adams E.H., Geller A., Senay E.C., Woody G.E., et al. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf 14 (2005) 851-859
19. Cohen H.W., Gibson G., and Alderman M.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 108 (2000) 2-8
20. Cruccu G., Anand P., Attal N., Garcia-Larrea L., Haanpää M., Jorum E., et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 11 (2004) 153-162
21. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. J Pain 3 (2002) 377-384
22. Dogra S., Beydoun S., Mazzola J., Hopwood M., and Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 9 (2005) 543-554
23. Dunner D.L., Wohlreich M.M., Mallinckrodt C.H., Watkin J.G., and Fava M. Clinical consequences of initial duloxetine dosing strategies: comparison of 30 and 60 mg QD starting doses. Curr Ther Res 66 (2005) 522-540
24. Dworkin RH. The efficacy of second-generation anticonvulsants in neuropathic pain. Presented at the 8th international conference on the mechanisms and treatment of neuropathic pain. San Francisco, 2005.
25. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 (2003) 1524-1534
26. Dworkin R.H., Corbin A.E., Young Jr. J.P., Sharma U., LaMoreaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
27. Eisenberg E., McNichol E.D., and Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293 (2005) 3043-3052
28. Estanislao L., Carter K., McArthur J., Olney R., and Simpson D. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 37 (2004) 1584-1586
29. Fava M., Mulroy R., Alpert J., Nierenberg A.A., and Rosenbaum J.F. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry 154 (1997) 1760-1762
30. Finnerup N.B., and Jensen T.S. Spinal cord injury pain: mechanisms and treatment. Eur J Neurol 11 (2004) 73-82
31. Finnerup N.B., Otto M., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
32. Freynhagen R., Strojek K., Griesing T., Whalen E., and Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115 (2005) 254-263
33. Furlan A.D., Sandoval J.A., Mailis-Gagnon A., and Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 174 (2006) 1589-1594
34. Galer B.S., Rowbotham M.C., Perander J., and Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80 (1999) 533-538
35. Gammaitoni A.R., and Davis M.W. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 36 (2002) 236-240
36. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 (2005) 1324-1334
37. Gimbel J.S., Richards P., and Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 60 (2003) 927-934
38. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
39. Gorson K.C., Schott C., Herman R., Ropper A.H., and Rand W.M. Gabapentin in the treatment of painful diabetic neuropathy: a placebo-controlled, double-blind, crossover trial. J Neurol Neurosurg Psychiatry 66 (1999) 251-252
40. Grainger J., Hammer A., Blum D., Silver M., and Quessy S. Double-blind, placebo-controlled trial of add-on lamotrigine in patients with neuropathic pain and inadequate relief with gabapentin, TCAs or non-narcotic analgesics. J Pain 7 (2006) S34
41. Grosskopf J., Mazzola J., Wan Y., and Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 114 (2006) 177-180
42. Grothe D.R., Scheckner B., and Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy 24 (2004) 621-629
43. Hahn K., Arendt G., Braun J.S., von Giesen H.-J., Husstedt I.W., Maschke M., et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 251 (2004) 1260-1266
44. Hall G.C., Carroll D., Parry D., and McQuay H.J. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122 (2006) 156-162
45. Hammack J.E., Michalak J.C., Loprinzi C.L., Sloan J.A., Novotny P.J., Soori G.S., et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98 (2002) 195-203
46. Hansson P.T., and Dickenson A.H. Pharmacological treatment of peripheral neuropathic conditions based on shared commonalities despite multiple etiologies. Pain 113 (2005) 251-254
47. In: Hansson P.T., Fields H.L., Hill R.G., and Marchettini P. (Eds). Neuropathic pain: pathophysiology and treatment (2001), IASP Press, Seattle, WA
48. Harati Y., Gooch C., Swenson M., Edelman S., Greene D., Raskin P., et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50 (1998) 1842-1846
49. Hardy T., Sachson R., Shen S., Armbruster M., and Boulton A.J.M. Does treatment with duloxetine for neuropathic pain impact glycemic control?. Diabetes Care 30 (2007) 21-26
50. Hempenstall K., Nurmikko T.J., Johnson R.W., A'Hern R.P., and Rice A.S.C. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2 (2005) 628-644
51. Hippisley-Cox J., Pringle M., Hammersley V., Crown N., Wynn A., Meal A., et al. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ 323 (2001) 666-669
52. Højsted J., and Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 11 (2007) 490-518
53. Hollingshead J., Dühmke R.M., and Cornblath D.R. Tramadol for neuropathic pain. Cochrane Database Syst Rev (2005) [Art. No.: CD003726]
54. Huse E., Larbig W., Flor H., and Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 90 (2001) 47-55
55. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., Malone R.M., Perhac J.S., Potisek N.M., et al. Predictors of opioid misuse in patients with chronic pain: prospective cohort study. BMC Health Serv Res 6 (2006) 46
56. Jensen M.P., Chodroff M.J., and Dworkin R.H. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 68 (2007) 1178-1182
57. Jovey R.D., Ennis J., Gardner-Nix J., Goldman B., Hays H., Lynch M., et al. Use of opioid analgesics for the treatment of chronic noncancer pain: a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manage 8 (2003) 3A-14A
58. Kalso E., Allan L., Dellemijn P.L.I., Faura C.C., Ilias W.K., Jensen T.S., et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 7 (2003) 381-386
59. Katz N.P., Adams E.H., Benneyan J.C., Birnbaum H.G., Budman S.H., Buzzeo R.W., et al. Foundations of opioid risk management. Clin J Pain 23 (2007) 103-118
60. Khoromi S., Cui L., Nackers L., and Max M.B. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 130 (2007) 65-75
61. Khoromi S., Patsalides A., Parada S., Salehi V., Meegan J.M., and Max M.B. Topiramate in chronic lumbar radicular pain. J Pain 6 (2005) 829-836
62. Kieburtz K., Simpson D., Yiannoutsos C., Max M.B., Hall C.D., Ellis R.J., et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 51 (1998) 1682-1688
63. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy. Neurology 63 (2004) 2104-2110
64. Levendoǧlu F., Oǧün C.O., Özerbil O., Öǧün T.C., and Uǧurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 29 (2004) 743-751
65. Loeser J.D. Cranial neuralgias. In: Loeser J.D., Butler S.D., Chapman C.R., and Turk D.C. (Eds). Bonica's management of pain. 3rd ed. (2001), Lippincott, Williams & Wilkins, Philadelphia 855-866
66. Manchikanti L., Cash K.A., Damron K.S., Manchukonda R., Pampati V., and McManus C.D. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician 9 (2006) 215-225
67. Martell B.A., O'Connor P.G., Kerns R.D., Becker W.C., Morales K.H., Kosten T.R., et al. Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146 (2007) 116-127
68. Mason L., Moore R.A., Derry S., Edwards J.E., and McQuay H.J. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328 (2004) 991-994
69. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987) 589-596
70. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326 (1992) 1250-1256
71. Meier T., Faust M., Hüppe M., and Schmucker P. Reduktion chronischer Schmerzen bei nichtpostherpetischen peripheren Neuropathien nach topischer Behandlung mit Lidocainpflaster. Schmerz 18 (2004) 172-178
72. Meier T., Wasner G., Faust M., Kuntzer T., Ochsner F., Hueppe M., et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 106 (2003) 151-158
73. Mercadante S., Arcuri E., Tirelli W., Villari P., and Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori 88 (2002) 239-242
74. Merskey H., and Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. (1994), IASP Press, Seattle [p. 212]
75. Meyer-Rosberg K., Kvarnström A., Kinnman E., Gordh T., Nordfors L.O., and Kristofferson A. Peripheral neuropathic pain: a multidimensional burden for patients. Eur J Pain 5 (2001) 379-389
76. Montgomery S.A., Tobias K., Zornberg G.L., Kasper S., and Pande A.C. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry 67 (2006) 771-782
77. Morley J.S., Bridson J., Nash T.P., Miles J.B., White S., and Makin M.K. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med 17 (2003) 576-587
78. Oxford Centre for Evidence-based Medicine. Levels of evidence and grades of recommendation. , [accessed 01.09.06].
79. Pandey C.K., Bose N., Garg G., Singh N., Baronia A., Agarwal A., et al. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg 95 (2002) 1719-1723
80. Raja S.N., Haythornthwaite J.A., Pappagallo M., Clark M.R., Travison T.G., Sabeen S., et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59 (2002) 1015-1021
81. Rajagopal A., Vassilopoulou-Sellin R., Palmer J.L., Kaur G., and Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to morphine. Cancer 100 (2004) 851-858
82. Raskin J., Pritchett Y.L., Wang F., D'Souza D.N., Waninger A.L., Iyengar S., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6 (2005) 346-356
83. Raskin J., Smith T.R., Wong K., Pritchett Y.L., D'Souza D.N., Iyengar S., et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med 9 (2006) 29-40
84. Raskin P., Donofrio P.D., Rosenthal N.R., Hewitt D.J., Jordan D.M., Xiang J., et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63 (2004) 865-873
85. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Symptoms and signs in patients with suspected neuropathic pain. Pain 100 (2004) 461-469
86. Ray W.A., Meredith S., Thapa B.P., Hall K., and Murray K.T. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 75 (2004) 234-241
87. Rice A.S.C., and Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94 (2001) 215-224
88. Rice ASC, Lever IJ, Zarnegar R. Cannabinoids and analgesia, with special reference to neuropathic pain. In: McQuay HJ, Kalso E, Moore RA, editors. Systematic reviews and meta-analyses in pain. Seattle: IASP Press; in press.
89. Richter R.W., Portenoy R., Sharma U., Lamoreaux L., Bockbrader H., and Knapp L.E. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6 (2005) 253-260
90. Rickels K., Pollack M.H., Feltner D.E., Lydiard R.B., Zimbroff D.L., Bielski R.J., et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 62 (2005) 1022-1030
91. Robinson L.R., Czerniecki J.M., Ehde D.M., Edwards W.T., Judish D.A., Goldberg M.L., et al. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Arch Phys Med Rehabil 85 (2004) 1-6
92. Roose S.P., Laghrissi-Thode F., Kennedy J.S., Nelson J.C., Bigger J.T., Pollock B.G., et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279 (1998) 287-291
93. Rosenstock J., Tuchman M., LaMoreaux L., and Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110 (2004) 628-638
94. Rowbotham M.C., Davies P.S., and Fields H.L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 37 (1995) 246-253
95. Rowbotham M.C., Davies P.S., Verkempinck C., and Galer B.S. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65 (1996) 39-44
96. Rowbotham M.C., Goli V., Kunz N.R., and Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 100 (2004) 697-706
97. Rowbotham M.C., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
98. Rowbotham M.C., Reisner L.A., Davies P.S., and Fields H.L. Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial. J Pain 6 (2005) 741-746
99. Rowbotham M.C., Twilling L., Davies P.S., Reisner L., Taylor K., and Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348 (2003) 1223-1232
100. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database of Syst Rev (2005) [Art. No.: CD005454]
101. Sabatowski R., Galvez R., Cherry D.A., Jacquot F., Vincent E., Maisonobe P., et al. Pregabalin reduces pain and improved sleep and mood disturbances in patients with postherpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109 (2004) 26-35
102. Schmader K.E. The epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 18 (2002) 350-354
103. Semple D.M., McIntosh A.M., and Lawrie S.M. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 19 (2005) 187-194
104. Serpell M.G. Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain 99 (2002) 557-566
105. Shlay J.C., Chaloner K., Max M.B., Flaws B., Reichelderfer P., Wentworth D., et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA 280 (1998) 1590-1595
106. Siddall P.J., Cousins M.J., Otte A., Griesing T., Chambers R., and Murphy T.K. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 67 (2006) 1792-1800
107. Sindrup S.H., Andersen G., Madsen C., Smith T., Brøsen K., and Jensen T.S. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 83 (1999) 85-90
108. Sindrup S.H., Bach F.W., Madsen C., Gram L.F., and Jensen T.S. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60 (2003) 1284-1289
109. Sindrup S.H., Otto M., Finnerup N.B., and Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96 (2005) 399-409
110. Smith D.G., Ehde D.M., Hanley M.A., Campbell K.M., Jensen M.P., Hoffman A.J., et al. Efficacy of gabapentin in treating chronic phantom limb and residual limb pain. J Rehabil Res Dev 42 (2005) 645-654
111. Tai Q., Kirshblum S., Chen B., Millis S., Johnston M., and DeLisa J.A. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized double-blind, crossover trial. J Spinal Cord Med 25 (2002) 100-105
112. Tasmuth T., Hartel B., and Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 6 (2002) 17-24
113. Tata L.J., West J., Smith C., Farrington P., Card T., Smeeth L., et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial, infarction. Heart 91 (2005) 465-471
114. 2-δ proteins. CNS Drug Rev 10 (2004) 183-188
115. Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2007; in press.
116. Thase M.E., Tran P.V., Wiltse C., Pangallo B.A., Mallinckrodt C., and Detke M.J. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharm 25 (2005) 132-140
117. The Pain Society. Recommendations for the appropriate use of opioids for persistent non-cancer pain: a consensus statement prepared on behalf of the Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Royal College of Psychiatrists. March 2004. , [accessed 16.05.06].
118. Thienel U., Neto W., Schwabe S.K., and Vijapurkar U. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 110 (2004) 221-231
119. Tremont-Lukats I.W., Challapalli V., McNichol E.D., Lau J., and Carr D.B. Systemic administration of local anesthetic agents to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 101 (2005) 1738-1749
120. Vallejo R., de Leon-Casasola O., and Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 11 (2004) 354-365
121. van de Vusse A.C., Stomp-van den Berg S.G.M., Kessels A.H.F., and Weber W.E.J. Randomised controlled trial of gabapentin in Complex Regional pain Syndrome type I. BMC Neurol 4 (2004) 13 10.1186/1471-2377-4-13
122. van Seventer R., Feister H.A., Young Jr. J.P., Stoker M., Versavel M., and Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 22 (2006) 375-384
123. Vinik A.I., Tuchman M., Safirstein B., Corder C., Kirby L., Wilks K., et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized double-blind, placebo-controlled studies. Pain 128 (2007) 169-179
124. Watson C.P.N., and Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
125. Watson C.P.N., Moulin D., Watt-Watson J., Gordon A., and Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105 (2003) 71-78
126. Watson C.P.N., Vernich L., Chipman M., and Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 51 (1998) 1166-1171
127. Watson C.P.N., Watt-Watson J.H., and Chipman M.L. Chronic noncancer pain and the long term utility of opioids. Pain Res Manage 9 (2004) 19-24
128. Wernicke J.F., Pritchett Y.L., D'Souza D.N., Waninger A., Tran P., Iyengar S., et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67 (2006) 1411-1420
129. Wiffen P., Collins S., McQuay H., Carroll D., Jadad A., and Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev (2006) [Art. No.: CD001133]
130. Wilder-Smith C.H., Hill L.T., and Laurent S. Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology 103 (2005) 619-628
131. Wilder-Smith O.H.G., and Arendt-Nielsen L. Postoperative analgesia: its clinical importance and relevance. Anesthesiology 104 (2006) 601-607
132. Wong GY, Michalak JC, Sloan JA, Mailliard JA, Nikcevich DA, Novotny PJ, et al. A Phase III double-blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: a North Central Cancer treatment Group study. Presented at the American Society of Clinical Oncology, Orlando, Florida, May 2005.
133. Yucel A., Ozyalcin S., Talu G.K., Kiziltan E., Yucel B., Andersen O.K., et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain 9 (2005) 407-416
134. Zacny J.P. Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. Drug Alcohol Depend 80 (2005) 273-278
135. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 69 (2003) 215-232